Woodline Partners’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-200,000
Closed -$618K 614
2023
Q3
$618K Sell
200,000
-48,000
-19% -$148K 0.01% 481
2023
Q2
$1.12M Buy
+248,000
New +$1.12M 0.01% 471
2020
Q4
Sell
-179,361
Closed -$5.4M 261
2020
Q3
$5.4M Buy
+179,361
New +$5.4M 0.18% 122